It’s still only November, but the Toronto Blue Jays look like the team that is going all-in this offseason. After a huge trade over the weekend, they haven’t slowed down, agreeing to sign outfielder Melky Cabrera to a two-year, $16 million deal. The story broke on ESPN Deportes, as Buster Olney of ESPN.com tweeted.
When Cabrera was suspended last season for using performance enhancing drugs, many pundits speculated he would cost himself as much as $50 to $60 million on the open market. The Blue Jays took advantage, getting a potential bargain signing here. They are only risking two years and – if PEDs were not what caused him to lead the National League in hits until his suspension last year – could get great production for small risk.
Cabrera is just 28 and hit .346 with 11 home runs and 60 RBI in 501 plate appearances for San Francisco last year. He is a career .284 hitter.
It appears that the Blue Jays see an open door with the Red Sox retooling, the Yankees aging, the Rays fading, and the Orioles possibly being a one-year wonder, and are going for it. They finished 73-89 in 2012 and haven’t made the playoffs since they won it all in 1993.